Afghanistan vs Benin: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Afghanistan
63.0%
in 2025
Benin
64.0%
in 2025
Afghanistan rank
140th
Benin rank
139th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Afghanistan
- Benin
How they compare
Benin currently reports 64.0% against 63.0% in Afghanistan, a difference of 1.0%.
Across all 18 years both countries report, Benin has been ahead every year.
Afghanistan ranks 140th and Benin ranks 139th of 192 countries.
Benin has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Afghanistan | Benin | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 36.3% | 60.2% | 23.9% | Benin |
| 2020s | 59.2% | 68.3% | 9.2% | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Afghanistan or Benin?
- Benin, at 64.0% against 63.0% in Afghanistan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Afghanistan and Benin?
- 1.0%, with Benin ahead.
- How many years of comparable data are there for Afghanistan and Benin?
- 18 years are reported by both, from 2008 to 2025.
- How do Afghanistan and Benin rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Afghanistan ranks 140th and Benin ranks 139th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.